Skip to content
Saturday, November 7, 2026
Flux Solutions Blog

Zimbabwe Turns Down ‘One-Sided’ US Healthcare Assistance Deal Due to Information Fears

Medical funding illustration
The offered American funding was aimed at initiatives for treating and preventing HIV/Aids, TB, and malaria.

Zimbabwe has declined a major US health deal valued at $367m (272 million pounds) over five years due to the United States' request for sensitive information.

The decision was revealed after a internal memorandum dated December was disclosed, revealing that President Emmerson Mnangagwa deemed the deal was "lopsided".

An official spokesman later clarified that the United States was requesting genetic material for scientific study and commercial purposes while was not willing to share the benefits from any future treatments.

"We are forced to start the challenging and unfortunate task of scaling back our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.

Her embassy indicated the US had furnished over $1.9bn for health programmes to Zimbabwe during the past twenty years.

A physicians' group in Zimbabwe has appealed for further dialogue to secure a deal agreeable to both sides so the country's vital HIV treatment initiative can continue.

Wider Implications

This rejection follows a comparable case in Kenya, where a high court blocked a related deal with the US after concerns were filed about the security of citizens' health data.

Since returning to office recently, US President Donald Trump has reduced overseas assistance and shut down the key foreign aid agency.

The agency had managed assistance for the US government, but Trump claimed its expenditure was "wasteful" and his administration was seeking government-to-government agreements to boost transparency and responsibility.

According to statements, 16 African countries have so far agreed to similar agreements, representing more than $18.3bn of fresh investment.

Details of the Declined Agreement

This assistance for Zimbabwe was intended to supported "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"We are confident this partnership could have provided immense benefits for Zimbabwean communities, especially the 1.2 million men, women and children currently on antiretroviral therapy through US-supported programmes," the Ambassador added.

However, official spokesman Nick Mangwana said the proposed deal was "unfair".

"Our nation was requested to provide its biological resources and data for a long time, with no equivalent assurance of benefiting from any scientific breakthroughs – such as new medicines or tests – that could be developed from that shared data," his statement read.

"Effectively, our nation would supply the basic resources for scientific discovery with no assurance that the resulting innovations would be available to our population should a future health crisis arise."

Sovereignty and Global Health

Mangwana further said that the US's withdrawal from the global health body and its push of one-on-one deals were upending frameworks previously set up via the international organization.

The spokesperson gave as an example its Pathogen Access and Benefit Sharing framework created to deal with potential global health emergencies.

"This system is intended to guarantee that when a country contributes its data, the resulting advantages – such as vaccines and treatments – are distributed fairly, not commercialised solely by those with the funds to create them."

These objections regarding the US deal "are not meant as hostility towards the US," Mangwana stressed.

"We encourage continued dialogue with our US partners on how subsequent collaboration could be structured in a way that honours the independence and interests of each country."

Medical Community Reaction

The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it acknowledged the official position, but recommended that negotiations must proceed since much of the country's Aids initiatives were funded by external financing.

"Where specific concerns exist, such as those relating to data governance or agreement terms, these can frequently be addressed through technical clarification and mutually agreed protections," it said.

The halted deal highlights the continuing tensions between receiving vital international aid and safeguarding a country's data in an ever more data-driven world.

Written by

Daisy Pace

Passionate cyclist and outdoor enthusiast with over a decade of experience in bike touring and gear testing.

Flux Solutions Blog

Type to search articles.